Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLC.
Kono SA, Weyant M, Franklin W, Gaspar LE, Camidge DR. Kono SA, et al. Among authors: camidge dr. Oncology (Williston Park). 2009 Apr 30;23(5):424-9. Oncology (Williston Park). 2009. PMID: 19476276
Dr. Camidge: To summarize, this patient is a relatively young, otherwise healthy female who is status post lobectomy. ...
Dr. Camidge: To summarize, this patient is a relatively young, otherwise healthy female who is status post lobectomy. ...
A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.
Hirsch FR, Kabbinavar F, Eisen T, Martins R, Schnell FM, Dziadziuszko R, Richardson K, Richardson F, Wacker B, Sternberg DW, Rusk J, Franklin WA, Varella-Garcia M, Bunn PA Jr, Camidge DR. Hirsch FR, et al. Among authors: camidge dr. J Clin Oncol. 2011 Sep 10;29(26):3567-73. doi: 10.1200/JCO.2010.34.4929. Epub 2011 Aug 8. J Clin Oncol. 2011. PMID: 21825259 Free PMC article. Clinical Trial.
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib.
Gan GN, Weickhardt AJ, Scheier B, Doebele RC, Gaspar LE, Kavanagh BD, Camidge DR. Gan GN, et al. Among authors: camidge dr. Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):892-8. doi: 10.1016/j.ijrobp.2013.11.010. Epub 2014 Jan 22. Int J Radiat Oncol Biol Phys. 2014. PMID: 24462383 Free PMC article.
Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.
Iyengar P, Kavanagh BD, Wardak Z, Smith I, Ahn C, Gerber DE, Dowell J, Hughes R, Abdulrahman R, Camidge DR, Gaspar LE, Doebele RC, Bunn PA, Choy H, Timmerman R. Iyengar P, et al. Among authors: camidge dr. J Clin Oncol. 2014 Dec 1;32(34):3824-30. doi: 10.1200/JCO.2014.56.7412. Epub 2014 Oct 27. J Clin Oncol. 2014. PMID: 25349291 Clinical Trial.
315 results